Trials / Unknown
UnknownNCT05892185
Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle Glaucoma
A Randomized, Single-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle Glaucoma.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Mingche Biotechnology CO., LTD · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the efficacy and safety of glaucoma device in the treatment of primary open-angle glaucoma.
Detailed description
A prospective, randomized, single-blind, positive control design was used to study primary open-angle glaucoma. Eligible subjects were screened and randomly assigned to the experimental group and the control group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GELA | GELA glaucoma implant |
| DEVICE | XEN | XEN gel stent implant |
Timeline
- Start date
- 2023-05-31
- Primary completion
- 2024-01-12
- Completion
- 2024-07-19
- First posted
- 2023-06-07
- Last updated
- 2023-06-07
Source: ClinicalTrials.gov record NCT05892185. Inclusion in this directory is not an endorsement.